Balyasny Asset Management
CSII

Balyasny Asset Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Balyasny Asset Management’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-50,000
Closed -$2.13M – 2568
2021
Q2 		$2.13M Buy
+50,000
New +$1.96M 0.01% 990

Other funds holding CSII

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Balyasny Asset Management's CSII Position: Q1 2023 in Review

Balyasny Asset Management sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2023, closing a stake of 720,791 shares — an estimated $9.82M sold.

Balyasny Asset Management first reported a position in CSII in Q1 2015 and held it in 16 quarters. The position peaked at $10.1M in Q2 2022. 150 funds tracked by Wall St. Rank hold CSII as of Q1 2023.

  • Balyasny Asset Management reported no remaining Cardiovascular Systems, Inc. position as of Q1 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 720,791 Cardiovascular Systems, Inc. shares in Q1 2023, an estimated $9.82M.
  • Balyasny Asset Management first reported a position in Cardiovascular Systems, Inc. in Q1 2015 and held it in 16 quarters.
  • Balyasny Asset Management's Cardiovascular Systems, Inc. position peaked at $10.1M in Q2 2022.
  • 150 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2023.

Based on Balyasny Asset Management's 13F filing for Q1 2023, filed 15 May 2023.